Who owns AVANIR Pharmaceuticals?

Key details on AVANIR Pharmaceuticals (Ticker: AVNR)

Who owns AVANIR Pharmaceuticals?

Is AVNR a good stock to own? Find out who bought AVANIR Pharmaceuticals, who sold AVANIR Pharmaceuticals (AVNR) stock, and who holds a large position in AVANIR Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Baker Bros. Advisors 30.33M $361.54M Sept. 30, 2014
T. Rowe Price Associates 25.56M $144.14M June 30, 2014
FMR 20.25M $241.35M Sept. 30, 2014
Jefferies 7.48M $89.14M Sept. 30, 2014
BlackRock Fund Advisors 7.42M $88.44M Sept. 30, 2014
STATE STREET CORPORATION 5.97M $71.15M Sept. 30, 2014
Vanguard 5.62M $66.99M Sept. 30, 2014
RA Capital Management 5.39M $64.21M Sept. 30, 2014
Invus Public Equities Advisors 5.15M $17.30M June 30, 2011
BlackRock Institutional Trust Company, N.A. 4.58M $54.56M Sept. 30, 2014
Ulys 3.65M $12.48M March 31, 2012
Millennium Management 3.62M $43.18M Sept. 30, 2014
TimesSquare Capital Management 3.45M $41.08M Sept. 30, 2014
GOLDMAN SACHS 3.04M $11.16M March 31, 2014
Artal Group S.A. 3.00M $35.76M Sept. 30, 2014
Wellington Management Company 2.68M $15.09M June 30, 2014
Westfield Capital Management Company 2.44M $29.08M Sept. 30, 2014
BVF 2.44M $10.33M Sept. 30, 2013
Adage Capital Partners GP 2.30M $10.58M June 30, 2013
SUSQUEHANNA INTERNATIONAL 2.15M $25.62M Sept. 30, 2014
OppenheimerFunds 2.00M $23.84M Sept. 30, 2014
NORTHERN TRUST 1.95M $23.23M Sept. 30, 2014
CR Intrinsic Investors 1.92M $5.26M March 31, 2013
Credit Suisse AG 1.89M $6.92M March 31, 2014
OrbiMed Advisors 1.86M $7.88M Sept. 30, 2013
CITADEL ADVISORS 1.69M $20.16M Sept. 30, 2014
Tang Capital Management 1.56M $3.20M Dec. 31, 2011

Who sold AVANIR Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Deerfield Management Company Dec. 31, 2011 2.66M $5.44M
QVT Financial March 31, 2011 2.06M $8.39M
Barclays March 31, 2011 1.54M $6.28M